PMC:7443692 / 42604-42886 JSONTXT

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T256","span":{"begin":0,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Understanding the impact of ACE2 variants on glycosylation and more importantly on S binding, especially for N546S, which impacts the glycan-glycan interaction between S and ACE2 (Figure 7), should be prioritized in light of efforts to develop ACE2 as a potential decoy therapeutic."}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2934","span":{"begin":28,"end":32},"obj":"Protein"},{"id":"T2935","span":{"begin":174,"end":178},"obj":"Protein"},{"id":"T2936","span":{"begin":244,"end":248},"obj":"Protein"}],"attributes":[{"id":"A2934","pred":"uniprot_id","subj":"T2934","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A2935","pred":"uniprot_id","subj":"T2935","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A2936","pred":"uniprot_id","subj":"T2936","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"Understanding the impact of ACE2 variants on glycosylation and more importantly on S binding, especially for N546S, which impacts the glycan-glycan interaction between S and ACE2 (Figure 7), should be prioritized in light of efforts to develop ACE2 as a potential decoy therapeutic."}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T102","span":{"begin":45,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"Understanding the impact of ACE2 variants on glycosylation and more importantly on S binding, especially for N546S, which impacts the glycan-glycan interaction between S and ACE2 (Figure 7), should be prioritized in light of efforts to develop ACE2 as a potential decoy therapeutic."}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T98","span":{"begin":45,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"Understanding the impact of ACE2 variants on glycosylation and more importantly on S binding, especially for N546S, which impacts the glycan-glycan interaction between S and ACE2 (Figure 7), should be prioritized in light of efforts to develop ACE2 as a potential decoy therapeutic."}